Physician profile
Lindsie E Hellwig
NPI 1396095899
$619.74
in general payments reported to CMS, 2019-2025
12 companies · $245 in 2025
The $245 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $186 · 2024: $189 · 2025: $245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $159.04 | 2023-2025 | Lutonix Drug Coated Balloon, Rotarexs 6 F X 135 Cm, Lifestream |
| Inari Medical, INC. | $141.54 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boston Scientific Corporation | $61.47 | 2024-2025 | Varithena Administration Pack |
| Asahi Intecc USA, INC. | $43.66 | 2024 | Peripheral Vascular |
| Medtronic, INC. | $43.03 | 2023-2024 | Closurefast, Venaseal, Ellipsys Vascular Access System |
| Convatec INC. | $38.81 | 2025 | |
| Penumbra, INC. | $37.53 | 2024 | Indigo System |
| Biosense Webster, INC. | $31.83 | 2025 | Nuvision Ice Catheter, Carto 3 |
| Globus Medical, INC. | $20.23 | 2025 | Senza |
| Merck Sharp & Dohme LLC | $17.44 | 2025 | Verquvo, Capvaxive |
| Becton, Dickinson and Company | $13.26 | 2024 | |
| Lemaitre Vascular, INC. | $11.90 | 2023 | Artegraft Vascular Graft |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsie Hellwig listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.